Our Purpose

Everything Argonaut Manufacturing Services does is aimed at improving the human condition. With a culture that attracts highly talented people, innovating superior products and services, we help our partners exceed their goals in the world of health. 

Like you, we Wanted a Better Solution for Contract Manufacturing

So we ventured out and created what we wanted most in a manufacturing service ourselves. We left our executive leader roles at Althea, Thermo Fisher, Affymetrix, Allergan, Ion Torrent, and other industry-leading organizations and built Argonaut Manufacturing Services to do Contract Manufacturing, Done Right.

We Understand, Because We Were in Your Shoes

A dream team with decades of experience has enabled us to design Argonaut Manufacturing Services to our high standards, with the customer in focus.

contract manufacturing organization life sciences diagnostics (IVD) aseptic fill and finish argonaut manufacturing services

Built by Industry Leaders with Decades of Experience

Built in State-of-the-Art Facilities

Argonaut Manufacturing Services: 100,000 square feet in five separate buildings within 5 miles proximity in Carlsbad, CA

We’d love to give you a tour of our buildings. Let us know!

And an Engaged Board of Directors

With 34 years of life sciences experience in senior management, R&D, operations, and quality, Rick was most recently the CEO of Althea Technologies Inc. Prior to Althea Technologies he was the senior director of operations at The Immune Response Corporation. Rick has significant experience in cGMP manufacturing, regulatory affairs, scale up, operational protocols, and team management. He also worked at Hybritech as a quality control analyst, research associate, and laboratory supervisor.

Before joining Telegraph Hill Partners, Paul Grossman was Head of Strategy and Corporate Development for Life Technologies, holding a similar position at Invitrogen Corporation prior to the merger with Applied Biosystems. Paul has held a variety of leadership and executive roles in R&D, Legal and Corporate Development teams, including spearheading the acquisition or divestment of more than 25 businesses

Gary has worked in the healthcare and medical device industry since 1981, including thirteen years as a senior executive in three private equity backed ventures. In 2005, Gary joined THP’s portfolio company Interface Catheter Solutions as President, CEO. He led the strategic growth into contract manufacturing resulting in its acquisition by NDC/Confluent Medical in 2015. Most recently, Gary was President of Trelyst, a subsidiary of NuSil Technology LLC, and is currently a Venture Partner for Telegraph Hill Partners.

Before joining Telegraph Hill Partners, Alex worked at Genzyme Corporation in the Oncology / Multiple Sclerosis Business Development Group, where he sourced, evaluated, and executed strategic M&A and licensing biopharma transactions. Prior to Genzyme, he worked as a portfolio manager at BlueMountain Capital Management, and as an investment banking analyst at Bank of America Securities.

Let's discuss the right solution for your team!